Neowise Biotech Licenses TCR Molecule to BeOne Medicines for Next-Gen Cell Therapy
CompanyDeals

Neowise Biotech Licenses TCR Molecule to BeOne Medicines for Next-Gen Cell Therapy

Nurix Therapeutics Announces Sanofi's Acquisition of STAT6 Program Rights
CompanyDeals

Nurix Therapeutics Announces Sanofi’s Acquisition of STAT6 Program Rights

MSD Presents Zilovertamab Vedotin Results at ASCO Annual Meeting
CompanyDrug

MSD Presents Zilovertamab Vedotin Results at ASCO Annual Meeting

Hanx Bio Files for Hong Kong IPO with ICBC International as Sole Sponsor
CompanyDeals

Hanx Bio Files for Hong Kong IPO with ICBC International as Sole Sponsor

R&B Biotech Receives FDA Approval for ZS805 Gene Therapy in Fabry Disease
CompanyDrug

R&B Biotech Receives FDA Approval for ZS805 Gene Therapy in Fabry Disease

GSK's Linerixibat NDA Accepted by FDA for Cholestatic Pruritus in PBC Patients
CompanyDrug

GSK’s Linerixibat NDA Accepted by FDA for Cholestatic Pruritus in PBC Patients

Shanghai Ark Bio and Partex Collaborate on ATR Inhibitor AK0658 Development
CompanyDeals

Shanghai Ark Bio and Partex Collaborate on ATR Inhibitor AK0658 Development

Bayer Files for Approval of Gadoquatrane MRI Contrast Agent in Japan
CompanyDrug

Bayer Files for Approval of Gadoquatrane MRI Contrast Agent in Japan

MicroPort CardioFlow to Acquire 49% Stake in La Ronda for RMB 171 Million
CompanyDeals

MicroPort CardioFlow to Acquire 49% Stake in La Ronda for RMB 171 Million